Effect of protease-activated receptor-2 deficiency on allergic dermatitis in the mouse ear

被引:76
作者
Kawagoe, J
Takizawa, T
Matsumoto, J
Tamiya, M
Meek, SE
Smith, AJH
Hunter, GD
Plevin, R
Saito, N
Kanke, T
Fujii, M
Wada, Y
机构
[1] Kowa Co Ltd, Div Pharmaceut, Tokyo Res Labs, Tokyo 1890022, Japan
[2] Univ Edinburgh, Ctr Genome Res, Edinburgh EH9 3JQ, Midlothian, Scotland
[3] Univ Strathclyde, Strathclyde Inst Biomed Sci, Dept Physiol & Pharmacol, Glasgow G4 0NR, Lanark, Scotland
关键词
protease-activated receptor-2; knockout mice; allergic dermatitis; contact hypersensitivity; passive cutaneous anaphylaxis;
D O I
10.1254/jjp.88.77
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To investigate the involvement of protease-activated receptor-2 (PAR-2) in allergic dermatitis, we generated PAR-2-deficient (PAR-2(-/-)) mice. Ear thickness, contact hypersensitivity (CH) induced by topical application of picryl chloride (PC) or oxazolone (Ox) after sensitization, and vascular permeability after ear passive cutaneous anaphylaxis (PCA) were compared between wild-type (WT) and PAR-2(-/-) mice. Ear thickness was almost the same in untreated WT and PAR-2(-/-) mice. Topical application of PC or Ox thickened the ears at 6, 24 and 48 h after challenge with a peak at 24 h in WT mice. In PAR-2(-/-) mice, the ear swelling induced by both PC and Ox was suppressed at every time point, and significant inhibition was found at 24 h in PC-induced CH and at 24 and 48 h in Ox-induced CH. Histopathological observation of the ears at 24 h after challenge revealed that PC- or Ox-induced ear edema and infiltration of inflammatory cells in WT mice were greatly attenuated in PAR-2(-/-) mice. The vascular permeability in the ears after PCA was not different between WT and PAR-2(-/-) mice. These results strongly suggest that PAR-2 plays a crucial role in type IV allergic dermatitis but not in type I allergic dermatitis.
引用
收藏
页码:77 / 84
页数:8
相关论文
共 49 条
[1]   Endoglin, an ancillary TGFβ receptor, is required for extraembryonic angiogenesis and plays a key role in heart development [J].
Arthur, HM ;
Ure, J ;
Smith, AJH ;
Renforth, G ;
Wilson, DI ;
Torsney, E ;
Charlton, R ;
Parums, DV ;
Jowett, T ;
Marchuk, DA ;
Burn, J ;
Diamond, AG .
DEVELOPMENTAL BIOLOGY, 2000, 217 (01) :42-53
[2]  
ASKENASE PW, 1983, J IMMUNOL, V131, P2687
[3]  
Boguniewicz M., 1996, ATOPIC DERMATITIS PA, P185
[4]   Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa [J].
Camerer, E ;
Huang, W ;
Coughlin, SR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) :5255-5260
[5]   HISTOLOGY OF AND QUANTITATIVE ASSAYS FOR OXAZOLONE-INDUCED ALLERGIC CONTACT-DERMATITIS IN MICE [J].
CHAPMAN, JR ;
RUBEN, Z ;
BUTCHKO, GM .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1986, 8 (02) :130-138
[6]  
CHER DJ, 1987, J IMMUNOL, V138, P3688
[7]   Protective effect of a PAR2-activating peptide on histamine-induced bronchoconstriction in guinea-pig [J].
Cicala, C ;
Spina, D ;
Keir, SD ;
Severino, B ;
Meli, R ;
Page, CP ;
Cirino, G .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 132 (06) :1229-1234
[8]   Protease-activated receptor-2 involvement in hypotension in normal and endotoxemic rats in vivo [J].
Cicala, C ;
Pinto, A ;
Bucci, M ;
Sorrentino, R ;
Walker, B ;
Harriot, P ;
Cruchley, A ;
Kapas, S ;
Howells, GL ;
Cirino, G .
CIRCULATION, 1999, 99 (19) :2590-2597
[9]   A protective role for protease-activated receptors in the airways [J].
Cocks, TM ;
Fong, B ;
Chow, JM ;
Anderson, GP ;
Frauman, AG ;
Goldie, RG ;
Henry, PJ ;
Carr, MJ ;
Hamilton, JR ;
Moffatt, JD .
NATURE, 1999, 398 (6723) :156-160
[10]  
Compton SJ, 1998, J IMMUNOL, V161, P1939